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Summary 
Ly-49 is a family of  type II transmembrane proteins encoded by a gene cluster on murine chro- 
mosome 6. One member of this family, Ly-49A, is expressed by a natural killer (NK) cell sub- 
set, binds to class I major histocompatibility complex (MHC) molecules, and blocks the killing 
of  target cells bearing the appropriate H-2 antigens. Here we show that another member of this 
family which is expressed by an NK cell subset, Ly-49C, recognizes H-2  b and H-2  d structures 
which are distinct from and overlapping with those recognized by Ly-49A. Interactions be- 
tween Ly-49A and C and their class I ligands are entirely blocked by the antibodies 5E6, YE1/ 
48, YE1/32, and A1, all of which were found to recognize epitopes contained within the car- 
bohydrate recognition domain (CRD).  However, cell-cell binding assays revealed that class I 
binding specificity is conferred by a combination of  sequences within both the CtLD and a 19- 
amino acid adjacent region. We also investigated the question of whether Ly-49A and C form 
dimers on cells which express both receptors. When coexpressed on COS cells, sequential im- 
munoprecipitation demonstrated that these receptors pair exclusively as homodimers, with no 
evidence for heterodimeric structures. These observations provide insight into both the bio- 
chemical nature of the Ly-49 family as well as the receptor functions of Ly-49C on NK cells. 
T 
he recognition of certain class I  MHC  molecules by 
natural killer cells may result in the delivery of an in- 
hibitory signal to the NK cell which prevents target cell ly- 
sis (1).  This inhibition can be overcome by blocking with 
antibodies against either class I MHC or NK cell receptors. 
In humans,  NK cell receptors for class I  MHC  include a 
novel family of molecules  (NKAT/p58)  whose members 
contain two or three external Ig domains (2-4). Individual 
members of this family are expressed by subpopulations of 
NK cells  and have distinct specificities for either HLA-C 
(5,  6)  or HLA-B alleles  (7, 8). Although it belongs to the 
molecularly unrelated C-type lectin supergene family (9), 
CD94 also  appears to function as an NK cell receptor for 
HLA-B (10). Antibodies against all of these receptors block 
the protection provided to a target cell by specific class I 
molecules. 
In mice, the Ly-49 family has been implicated in class I 
recognition by NK cells,  cDNAs encoding eight members 
of this  family have  been  identified  (Ly-49A-H)  (11-15), 
and polymorphism of individual members has also been re- 
ported (Ly-49A, C, and G)  (16-18).  Studies using mono- 
clonal antibodies which recognize specific members of this 
family have shown overlapping NK cell subset expression 
for Ly-49A  (20%),  Ly-49C  (30%),  and  Ly-49G.2  (50%) 
(15,  18--20).  Ly-49A binds to H-2D  a and D k (21, 22) and 
inhibits  the  lysis  of target  cells  expressing these  antigens 
(19).  Ly-49G.2  + NK cells appear to be inhibited by H-2  a 
antigens (possibly in a manner distinct from Ly-49A) (18), 
although a physical interaction between Ly-49G.2 and H-2 
antigens has not been demonstrated. 
Bone marrow transplantation studies have implicated Ly- 
49C + (5E6  +) NK cells in the recognition of class I MHC. 
This subset mediates the rejection of BALB/c (H-2d), but 
not C57BL/6 (H-2b), bone marrow when injected into le- 
thally irradiated F I recipients (20).  Cell-cell binding exper- 
iments in COS cells have demonstrated that Ly-49C binds 
to  a  wide  range  of cell lines,  most likely through  class I 
MHC (15).  This binding appears to involve carbohydrates 
on  class I  MHC  (23),  a property also  shared  by Ly-49A 
(24).  All Ly-49 molecules contain an  extracellular region 
homologous  to  the  carbohydrate  recognition  domain 
(CRD) 1 of C-type lectins  (14,  15)  which  is  thought  re- 
sponsible for their lectin activity. 
In  this  study we  have  examined the  specificity of the 
class I MHC ligands  of Ly-49C, and have found these to be 
1Abbreviation used in this paper: CRD, carbohydrate  reco~lition domain. 
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Ly-49A and C  have demonstrated that although anti-Ly-49 
Abs recognize epitopes in the CRD and block cell-cell ad- 
hesion, hgand specificity is  not entirely conferred by this 
domain. Additionally, these receptors exclusively form ho- 
modimers when simultaneously expressed in COS cells. 
Materials  and Methods 
Ly-49A and C Chimeras.  The Ly-49A cDNA (position 142- 
1079) was subcloned into the Sstll  site of plasmid BS KS+  and 
the  Ly-49C  cDNA  (position 59-931)  was  subcloned into  the 
EcoKI-HindlIl sites of pBS KS+, and each  were used as tem- 
plates for all PCK reactions that amphfied portions of the respec- 
tive cDNAs. Chimeric constructs were generated by PCR ampli- 
fication of regions  of the Ly-49A and Ly-49C cDNAs using the 
oligonucleotides listed below, followed by the fusion of these am- 
plified products via engineered restriction enzyme sites contained 
within the  oligonucleotide sequence (small case letters  refer  to 
such sequences as well as linker sequences).  The template source 
for each primer is indicated by its prefix (A-Ly-49A, C-Ly-49C); 
A I:ggaattctcgagTCCTTACAGCACACA; A2:ggaattctcgagAAC- 
AGTCTTGGTTTT; A3:ggggtaccTTAATACAGGAAACA;  A4: 
ggaattctatcgatTTATTTTTCAGCAT; A5:ggaattctcgagTCCTcA- 
CcGgACACAGGCAGAGGTGATAAA;  CI:ggaattctcgagAAC- 
AGTCTTTGTTTT;  C2:ggaattctcgagAACAGTCTTTGTTTT; 
C3:ggggTACCTTTAATCTGGT;  C4:ggaattcaaatcgATAGATTG- 
TAGGCCAAGC; C5 :ggaattctcgagTCCTtACaGcACACAGGC- 
AGAGGTGTTAAA, 
The following primer combinations were used to amplify por- 
tions of Ly-49A and Ly-49C cDNAs (the position of the termini 
of the amplified products on the full-length Ly-49A cDNA [11] 
and Ly-49C cDNA [13] are in parenthesis):  A5/A3 (586-1032); 
A1/A3 (567-1032); A2/pBS forward (142-567); A4/pBS forward 
(142-502);  C5/C3  (511-912);  C1/C3  (494-912);  C4/C3  (415- 
912); C2/pBS reverse (59-494).  All amplified products were sub- 
cloned into pBS KS+ and sequenced in their entirety to confirm 
that only specified mutations had occurred. The chimeric con- 
structs were generated as follows,  with the domain designations 
(see Fig.  6 A)  in parenthesis:  (a)  A5/A3  (CRDA) was fused to 
C2/pBS reverse (NH2C) using the engineered Xhol site; (b) C5/ 
C3 (C1LDC) and C1/C3 (CR.DC +  IC) were fused to A2/pBS 
forward (NH2A) using the engineered Xhol site; and (c) C4/C3 
(CP,  DC  +  IC +  IIC) was fused to A4/pBS forward (NH2A  - 
IA -  IIA) using the engineered Clal site. 
Cell Lines and Transfections.  The cell lines COS-l, A20,  IC- 
21,  P,l.1,  GM979,  20-8-4S,  34-2-12S, 34-5-8S,  34-1-2S, B8- 
24-3,  K7-65,  Y3,  28-14-8S,  28-11-5S,  3-83P were  purchased 
from American Type Culture Collection (Rockville, MD)  and 
were cultured in DMEM +  5% FCS. Ly-49 cDNAs were cloned 
into the vector pAX142 and expressed in COS cells by a DEAE- 
dextran method as previously described  (15). The Ly-49C cDNA 
was originally obtained from a (C57BL/6 X CBA)F  1 library and 
the sequence was correctly  submitted to GenBank, but its pubh- 
cation contained a typographical  error (13). Nucleotide positions 
195-196 were inadvertently  printed as A-T, but are actually C-A. 
This clone has recently been demonstrated to  be CBA-derived 
(16) and is identical to the Ly-49C allele found in BALB/c mice 
(17). The Ly-49D cDNA was obtained by screening a B10.D2 
IL-2 activated  NK cell cDNA library  with an Ly-49A radiola- 
beled probe. The sequence of this clone differs from that previ- 
ously reported for Ly-49D at two nucleotide positions, neither of 
which result in amino acid changes (14). We have found an ade- 
nine and a guanine at nucleotides 65 and 79, respectively, whereas 
Smith et al. have reported a guanine and adenine at these  posi- 
tions (14). 
Antibodies and Flow Cytometry.  R-PE-conjugated  5E6  and 
FITC-conjugated  AI were purchased from PharMingen (San Di- 
ego, CA), and YE1/48, YE1/32, and 5E6 were purified from tis- 
sue culture supernatants  using protein G-Sepharose 4 Fast Flow 
(Pharmacia  LKB,  Piscataway,  NJ).  The  5E6  bybridoma  was 
kindly  provided  by  Dr.  Vinay  Kumar  (University  of  Texas 
Southwestern Medical Center, Dallas, TX). Cell staining proce- 
dures were carried out for 30 min at 4~  at concentrations of 107 
cells/ml, followed by two  washes  in PBS  containing 2%  FCS. 
Those samples stained with YE1/48 or YE1/32 required a sec- 
ondary step  with  a  goat  anti-rat FITC Ab.  Analysis was  per- 
formed  on a  FACSort  |  (Becton  Dickinson &  Co.,  Mountain 
View, CA), and dead cells were stained with propidium iodide (1 
Ixg/ml in final wash) and gated out. 
Adhesion Assays.  One  d  following transfection,  COS  cells 
were trypsinized and transferred to 6 cm dishes (3002; Falcon Lab- 
ware,  Oxnard, CA) at 2  ￿  10  s cells/plate.  3 d post transfection, 
cells tested  for adhesion to  COS  cells were labeled  for 45  rain 
with 1 I~Ci  of NaSlCrO4/106  cells, washed twice, incubated with 
the appropriate  Ab for 30 min, and then plated ("~5 ￿  10  ~' cells in 
1.5  ml).  Purified YE1/48,  YE1/32,  and 5E6  were  added  at  a 
concentration of 5 txg/ml and all anti-class I MHC Abs were used 
as  1:10  dilutions of tissue culture supematants.  Adhesion assays 
were carried out for 2 h at 37~  after which plates were washed 
three times with prewarmed media, bound cells were lysed with 
10% Triton X-100, and radioactivity  was determined. 
Experiments which measure  cpm bound were done in tripli- 
cate and values presented are the mean +__ SD. Values expressed as 
percent control adhesion are relative to plates tested under identi- 
cal conditions except for a preincubation step with media rather 
than an Ab. These numbers represent the mean +_ SEM of at least 
three independent experiments. 
lmmunoprecipitation.  COS  cells were  surface  biotinylated as 
described (25) and lysed with lysis buffer (1% Triton X-100 in 10 
mM Tris-C1 [pH 7.5], 150 mM NaC1). The cell lysates were cen- 
trifuged at the maximum speed in an Eppendorf microcentrifuge 
for 15 rain at 4~  The cleared  cell lysates were incubated with 
anti-Ly-49-coupled beads  (50  I*1  of 50%  suspension in  lysis 
buffer) for 1 h at 4~  with continuous mixing. The beads were 
then washed with the lysis  buffer four times, and the bound pro- 
teins were eluted from the beads with 200 Ixl of 0.1 M  Glycine- 
C1 buffer (pH  2.9)  containing 1% Triton X-100 and 150  mM 
NaC1.  The pH of the eluents was neutralized with a predeter- 
mined amount of I M Tris-Cl (pH 8.0). A portion of each eluent 
was subjected to Western blotting, and the rest was used for a sec- 
ond round of immunoprecipitation.  The neutralized eluents were 
incubated with second set of antibody-coupled beads for 1 h  at 
4~  with continuous mixing. The beads were then washed with 
the lysis buffer,  and the bound proteins were eluted with SDS- 
PAGE  loading buffer.  The  eluted  proteins were  subjected to 
Western blotting and probed with peroxidase-conjugated strepta- 
vidin by the ECL chemiluminescence  method (Amersham Corp., 
Arlington Heights,  IL)  according to the manufacturer's instruc- 
tions. 
Results 
Domain Specificities of Anti-Ly-49 Antibodies.  Several an- 
tibodies  have  been  produced  that  recognize  members  of 
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Figure 1.  Domain specificities ofanti-Ly-49 antibodies. Chimeric Ly- 
49A/C cDNAs (see Materials and Methods) were transiently expressed in 
COS cells and tested for reactivity with YE1/48, YE1/32, A1, and 5E6. 
Domain abbreviations are as follows: cyt, cytoplasmic, TM,  transmem- 
brane, CRD, carbohydrate recognition domain. The numbers presented 
were obtained by flow cytometry and represent the mean fluorescence  in- 
tensity following subtraction of background values (COS cells transfected 
with vector alone and stained with the specific Ab). 
Ly-49D 
YEl/48  YE1/32  A1 
Figure 2.  Cross-reactivity  of anti-Ly-49A antibodies. Ly-49A and Ly- 
49D were expressed in COS cells and stained with YE1/48, YE1/32, and 
A1. Solid histograms represent cells transfected with Ly-49A or D, and 
empty histograms are cells transfected with vector alone. 
the Ly-49 family (20, 26-28). In a previous study, we dem- 
onstrated that YE1/48 and YE1/32 recognize Ly-49A, and 
that 5E6 is specific for Ly-49C (15).  No cross-reactions of 
these  antibodies  could  be  detected  with  any  of the  five 
Ly-49 molecules characterized at that time. To characterize 
the domains recognized by these antibodies  (and the anti- 
Ly-49A antibody  A1),  we  have  constructed  chimeras  of 
Ly-49A and Ly-49C which swap  the  CRD  of one mole- 
cule onto the amino terminus of the other (Fig.  1). Expres- 
sion of these constructs in COS cells  and subsequent FACS 
analysis has shown that all of the antibodies  are specific for 
epitopes contained entirely within the CRY). Staining with 
all antibodies was identical to that of the parental molecule 
(Fig.  1). 
Analysis  of Ly-49  cDNAs  which  have  recently  been 
cloned has revealed a high degree of similarity between Ly- 
49A and Ly-49D in the  carbohydrate  recognition domain 
(90% identity)  (14).  Having shown that all anti-Ly-49 Abs 
are specific for CRD-epitopes, we therefore speculated that 
this  high degree of similarity may result in  cross-reactivity 
of Ly-49D with some or all anti-Ly-49A antibodies. When 
expressed  in  COS  cells,  however,  Ly-49D  showed  only 
weak  reactivity  with  YE1/48  when  compared  with  Ly- 
49A, and no binding to YE1/32, A1, or 5E6 (Fig. 2). 
Distinct  Class I MHC  Specificities of Members of the Ly-49 
Family.  COS  cells  expressing  Ly-49A,  C,  and  D  were 
tested for their ability to bind cell lines representing four dif- 
ferent haplotypes (H-2  d,k, b. ,ha ,~). Each of the three Ly-49s 
was found  to  have  a  unique  recognition  pattern.  Ly-49C 
bound all haplotypes tested,  Ly-49A bound H-2  a"na k, and 
Ly-49D bound weakly but consistently to H-2  k (Fig. 3). 
Antibody blocking experiments  with  the  H-2  a cell line 
demonstrated the specificity of Ly-49A for D d, but not K d 
(Fig. 4 A). As reported previously (19, 22), an Ab recogniz- 
ing  the  o~l/oL2  domain  (34-5-8S)  entirely  blocked  adhe- 
sion, whereas an Ab against the or3 domain (34-2-12S) had 
no effect. Ly-49C-mediated adhesion was partially blocked 
by antibodies  specific for either K d (20-8-4S)  or D d (34-5- 
8S),  and  entirely blocked by the  simultaneous  addition  of 
both antibodies  (Fig. 4  B), suggesting that Ly-49C binds to 
both D a and K d. This was further supported by the total in- 
I 
I 
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hibition seen with an Ab recognizing both K d and D a (34- 
1-2S).  As  was  seen  with  Ly-49A,  the  antibody  directed 
against the etl/ot2, but not e~3, domain ofD d inhibited Ly- 
49C-mediated  adhesion.  Anti-Ly-49  antibodies  inhibited 
the interaction of both Ly-49A (YE1/32 and YE1/48)  and 
Ly-49C (5E6) with the H-2  d cell line (Fig. 4, A  and B). 
A  panel  of well characterized anti-H-2 b Abs has shown 
that  Abs  which  recognize  K b  entirely  inhibit  Ly-49C- 
mediated adhesion, whereas Abs against D b are non-inhibi- 
tory (Fig. 4  C). Binding of an H-2  s cell line was also inhib- 
A  H-2  d  H-2  b 
Ly-49A 
Ly-49C B 
Ly-49D B 
pAX142 
I 
0  10  20  1~0 
C  H-2  s  H-2  k 
B 
Ly-49A I 
Ly-49C 
Ly-49D  I 
pAX142  I ~ 
0 
D 
20 
Ly-49A  Ly-49A 
Ly-49C  ~  Ly-49C  R" 
Ly-49D  Ly-49D reel 
pAX142  pAX142  1 
0  10  20  30  5  10 
cpm bound (x 1000) 
Figure 3.  Cell-cell binding mediated by Ly-49A, C and D. Cell lines 
representing four  haplotypes (H-2d/A20, H-2b/IC-21,  H-2VGM979, 
H-2k/IK1.1) were labeled with 51Cr and overlaid on COS cells transfected 
with an Ly-49 cDNA or vector alone (pAX142). Plates were washed after 
2 h  and radioactivity was determined, The numbers presented are the 
mean +  SD of triplicate plates. A 
2o.e-4s (K,Q 
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Figure  4.  Distinct  class I  MHC  specificities of  Ly-49A  and  C. 
51Cr-labeled cell lines (H-2  a, H-2  b, H-2') were incubated for 2 h with 
Ly-49A- or C-transfected COS cells in the presence of antibodies against 
either class I MHC or Ly-49 (the antigenic specificities  of each antibody is 
in parentheses next to the clone name). 100% control adhesion represents 
binding in the absence of antibody, and 0% adhesion is the level of the 
cell line binding to COS cells transfected with vector alone. Values pre- 
sented are the mean +  SEM of  at least three independent experiments. 
ited by Abs against class I  MHC  (Fig. 4  D),  although  the 
nature of the H-2  ~  structures recognized by these antibodies 
is not characterized. Additionally, 5E6 completely blocked 
adhesion  to  both  the  H-2  b and  H-2'  cell lines  (Fig.  4,  C 
and D). All anti-H-2  k Abs tested were found to be ineffec- 
tive at blocking the  interaction between  Ly-49A and  D k, 
and  were  therefore  not  tested  with  Ly-49C  and  Ly-49D 
(data not shown). 
Ly-49A  and  C  Form Homodimers but  not  Heterodimers. 
Approximately 5% ofC57BL/6  (B6) NK cells express both 
Ly-49A  and  Ly-49C  (15).  Each  of these  receptors  have 
been  characterized as  disulfide-linked dimeric  cell surface 
antigens  of similar size  and  highly related  amino  acid se- 
quences  (11-13,  20). We therefore evaluated the ability of 
these related molecules to form heterodimers when  simul- 
taneously expressed in COS  cells. COS  cells cotransfected 
with  Ly-49A and  C  cDNAs  expressed both  Ly-49 mole- 
cules on the cell surface as shown by flow cytometric anal- 
ysis (Fig. 5  A). Ly-49 on these cells were immunoprecipi- 
tared by either anti-Ly-49A CYE1/48) or anti-Ly-49C (5E6), 
and  the  resultant immunoprecipitates were  subjected to  a 
second round ofimmunoprecipitation with anti-Ly-49 an- 
tibodies.  If Ly-49A  and  C  formed  heterodimers  on  the 
transfected COS  cells, Ly-49 precipitated by anti-Ly-49A 
in the first round ofimmunoprecipitation should have been 
reprecipitated by anti-Ly-49C in the second round of im- 
munoprecipitation and  vice versa.  As shown  in  Fig.  5  B, 
Figure 5.  Lack of molecular association between Ly-49A and C.  (A) 
COS cells were transfected with either Ly-49A, Ly-49C, Ly-49A and C, 
or vector alone (pAX142). After 3 d, cells were stained with A1-FITC + 
5E6-PE and analyzed by flow cytometry. (B) Transfected COS cells were 
surface  biotinylated and  Ly-49  was  immunoprecipitated  (ip)  by  either 
anti~Ly-49A (YE1/48)  or anti-Ly-49C (5E6).  Aliquots of the immuno~ 
precipitates were either directly analyzed or subjected to a second round 
of immunoprecipitation using anti-Ly-49 as indicated. All of the immu- 
noprecipitates were analyzed by Western blotting using peroxidase-con- 
jugated streptavidin as a probe. The positions of the molecular mass stan- 
dard are indicated (kD). 
the Ly-49 dimers precipitated by anti-Ly-49 antibodies in 
the first round of immunoprecipitation were reprecipitated 
by the same antibodies in the second round but not by dif- 
ferent anti-Ly-49 antibodies. An extended exposure of the 
same blot shown in Fig. 5  B also gave no indication of re- 
precipitation with a different antibody in the second round 
(data not shown), indicating that heterodimers were either 
not present or that  their formation was  a  rare  occurrence 
compared to that expected for random dimerization of the 
two polypeptide chains. 
Ligand Binding Domains of Ly-49.  Ly-49A and  C  each 
contain an extracellular C1LD  of ~125  amino acids which 
accounts for 60%  of the extracellular portion of the mole- 
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strated  that  all  anti-Ly-49  Abs  tested  are  reactive  with 
epitopes found within the CRD. This same set of chimeras 
was also tested in cell-cell binding assays to localize the re- 
gion  of Ly-49s responsible  for ligand  recognition.  It was 
found that when either the CRD  of Ly-49C is transplanted 
onto the amino terminus  of Ly-49A, or vice versa, neither 
of the  chimeric  molecules bound the  same  wide  range  of 
cell lines as does Ly-49C (Fig. 6 A). However, both chime- 
ras bound  to  the  H-2  a and k cell lines  which  are  normally 
bound by the parental molecules. 
An  extension  of this  analysis  has  shown  that  H-2  b and 
H-2  s binding is recovered in a chimera that includes an ad- 
ditional 32, but not 6, Ly-49C-specific amino acids in the 
region immediately adjacent to the CRD  (Fig. 6, A  and B). 
Residue(s)  required  for  Ly-49C-specific  binding  may 
therefore be narrowed to a 26-amino acid area. Exclusion 
of those  residues  shared  by Ly-49A and C  at  the  carboxy 
and amino  ends  of this  region allows for a  greater refine- 
ment  to  a  19-amino  acid segment  required  for H-2  b and 
H-2  s binding.  This  region  is  characterized  by  10  amino 
acid  differences  between  the  two  molecules  as  well  as  a 
stretch  of four amino  acids  deleted  in Ly-49A. Ly-49D is 
the  only  other  of the  eight  Ly-49  cDNAs  that  has  this 
same deletion (14). 
Discussion 
The  results  presented  above  demonstrate  that  Ly-49C 
binds a range of class I MHC  molecules, including K a, D a, 
and K b, but not D b. In addition, Ly-49D also weakly binds 
to an H-2  k cell line.  These findings support the hypothesis 
that Ly-49 is a family of NK cell receptors with related, but 
distinct, functions. Ly-49A and Ly-49C differ in both their 
pattern  of expression  by NK  cell  subsets,  as  well  as  their 
specificities  for  class  I  molecules.  Interestingly,  both  of 
these properties overlap between the two molecules, in that 
they both bind to H-2D  a and N5% of B6 NK cells coex- 
press both receptors (15). 
The related sequence and disulfide-linked dimeric struc- 
ture  of Ly-49A and  C  suggests  that  these  molecules  may 
form  heterodimers  in  cells  that  express  both  receptors. 
However,  when  both  Ly-49A and  C  are  simultaneously 
expressed  in  COS  cells  and  sequentially  immunoprecipi- 
rated with antibodies  against Ly-49A followed by Ly-49C, 
or  vice  versa,  only  homodimeric  structures  are  detected. 
This suggests that Ly-49A+C  + NK cells possess two sets of 
distinct  Ly-49  homodimers,  and  no  Ly-49A/C  het- 
erodimers.  It is  therefore  likely  that  such  double  positive 
NK cells recognize the full range of class I molecules recog- 
nized  by  Ly-49A and  C,  rather  than  a  potentially  novel 
specificity  recognized by a  heterodimer.  Allelic  exclusion 
Figure 6.  Ligand  binding domains of Ly-49. (A) Chimeric Ly-49A/C 
cDNAs (see materials and methods) were transiently expressed in COS 
cells and tested for binding (+/-)  to H-2  d (A20), H-2  k (R1.1), H-2  b 
(IC-21), and H-2  s (GM979) cell lines. Regions representing Ly-49A and 
Ly-49C sequence are in gray and black, respectively. Amino acid se- 
quence comparison  is shown for a portion of the extracellular region im- 
mediately adjacent to the ClkD  (  identity; ￿9 gap).  TM indicates 
the location of the transmembrane segment, cyt designates the cytoplas- 
mic domain, and * identifies amino acid residues differing between Ly- 
49C  B^LB and Ly-49C  B6 (16, 17). (B) Binding of  Ly-49A/C chimeras to an 
H-2  b cell line (IC-21). After a 2-h coincubation with transfected COS 
cells at 37~  unbound cells were washed away and plates were photo- 
graphed. (I) Ly-49C; (2) Ly-49C (CRD)/Ly-49A (amino terminus); (3) 
Ly-49C (CRD +  I + II)/Ly-49A (amino terminus). 
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heterodimers  within  a single NK cell  (16).  Such  a mecha- 
nism prevents the potential pairing of the highly similar al- 
loforms of Ly-49A and C  (92-98% amino acid identity)  in 
a  heterozygous  animal  and  thereby  maintains  a  single  re- 
ceptor specificity. 
By  constructing  chimeras  between  Ly-49A  and  C  we 
have  characterized  domains  essential  for ligand  specificity. 
In a  cell-cell  adhesion  assay, Ly-49C binds  to cell lines  of 
H-2  b  and ~ haplotypes,  whereas  Ly-49A  does  not.  We 
found  that  the  CRD  of Ly-49C  spliced  onto  the  amino 
terminus of Ly-49A was unable to confer the binding char- 
acteristics of the entire Ly-49C polypeptide. Additional Ly- 
49A/C  chimeras revealed a  19-amino  acid stretch adjacent 
to  the  CRD  required  for  Ly-49C--specific  binding.  Al- 
though this demonstrates that sequences in this area are es- 
sential in determining the ligand specificity of Ly-49C, this 
region  is  clearly  not  the  sole  determinant.  Chimera  with 
the  CRD  of Ly-49A spliced onto  the  stem of Ly-49C  do 
not bind to H-2  b and H-2  ~ cell lines.  These data therefore 
demonstrate  that  a  combination  of sequences  within  the 
CRD  as well as in the adjacent stem region are essential de- 
terminants of Ly-49 ligand specificity. 
We have previously shown that Ly-49C binds some car- 
bohydrates and that carbohydrates on class I MHC  seem to 
be important for interactions with Ly-49C (23). Our results 
reported here, combined with these previous observations, 
suggest that this binding may be mediated by the carbohy- 
drates  as  well as  the  peptide  backbone  of class I  MHC  si- 
multaneously  interacting  with  distinct  domains  of Ly-49. 
Such  a  model  predicts  that  not  only  the  level  of class  I 
MHC  on  a  target  cell,  but  also  its  glycosylation  pattern, 
may regulate its sensitivity to NK cells. An alternate expla- 
nation  of these  chimeric  Ly-49 findings  is that binding  to 
class  I  MHC  is mediated by either the  CRY)  alone  or the 
stem alone, but the specificity may be altered by structural 
changes in an adjacent region.  Further  studies are required 
to test these hypotheses. 
Ly-49C + NK cells derived from (C57BL/6  X BALB/c)F l 
(CB6F0  mice  lyse  parental  BALB/c  (H-2a),  but  not  B6 
(H-2b),  Con  A  blasts  (29).  Ly-49C  has  been  proposed  to 
transmit negative signals upon interaction  with  K b.  This is 
supported  by  the  observation  that  K b bearing  targets  are 
lysed  following  preincubation  with  anti-5E6  (Fab')2,  im- 
plying  that  the  delivery  of  a  negative  signal  through 
Ly-49C is being blocked  (29).  Additionally,  Ly-49C + NK 
cells derived  from a  homozygous BALB/c mouse  are  un- 
able  to  lyse BALB/c  blasts,  and  preincubation  with  anti- 
5E6 results in lysis of these targets as well (29). The sugges- 
tion that Ly-49C interacts with class I and delivers negative 
signals is supported by our binding studies  that have dem- 
onstrated that Ly-49C binds to H-2  b (K  b, but not D b) and 
H-2 a (K  d and D d) structures. However, the lysis of BALB/c 
blasts by CB6F 1 Ly-49C + NK cells indicates that H-2 d class 
I molecules cannot, at least under some circumstances, pro- 
vide the proper protective signal to Ly-49C + NK cells. 
One  explanation  for this  apparent paradox is that allelic 
forms of Ly-49C may have different class I specificities and 
or affinities.  The  Ly-49C  used  in  these  binding  studies  is 
the BALB/c  allelic form, and differs from the recently de- 
scribed  B6  receptor  by  14  extracetlular  amino  acids  (16, 
17).  Four of these differences  (indicated  by *  in Fig,  6  A) 
are in the  19-amino  acid stem region which has been im- 
plicated in the  determination  of ligand specificity.  The al- 
lelic exclusion  that has been demonstrated  for Ly-49A and 
C  (16)  predicts  that  a  CB6F l  mouse  has  two  subsets  of 
Ly-49C +  NK  cells:  Ly-49C  13ALB  and  Ly-49C  Bt.  The 
Ly-49C  B6 fraction may therefore be responsible for reactiv- 
ity against BALB/c  targets,  whereas  both  the  Ly-49C  BALB 
and Ly-49C B6 fractions appear to be inhibited  by H-2  b an- 
tigens (20, 29). Alternatively, the education process in an F~ 
mouse  may calibrate  Ly-49C  receptor levels by a  mecha- 
nism similar to that demonstrated  for Ly-49A  (30),  result- 
ing in the reactivity ofLy-49C + NK cells against homozy- 
gous H-2 a targets. Resolution of these questions will require 
an evaluation of the binding properties of the Ly-49C/36 re- 
ceptor as well as a more precise characterization of the means 
by which class I MHC  affects lysis by Ly-49C + NK cells. 
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